Update in Neurology
Authors: Martin A. Samuels
Journal: Annals of Internal Medicine (1996)

Updates from the Annual Session1 October 1996Update in NeurologyMartin A. Samuels, MDMartin A. Samuels, MDFrom Brigham and Women's Hospital, Boston, Massachusetts.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-125-7-199610010-00007 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail The recent major advances in neurology have focused primarily on the prevention and treatment of stroke. Until recently, the care of the patient who had had a stroke was often limited to getting the patient to an emergency department, obtaining a computed tomographic scan to rule out a hemorrhage, initiating heparin therapy, and observing the patient. Not much more was available until rehabilitation began. This strategy is no longer acceptable. Because of recent advances, more strokes can be prevented and patients can be treated more effectively than in the past.Other recent neurologic advances include new drug therapy for epilepsy, ...References1. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1991; 325:445-53. Google Scholar2. European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group. Lancet. 1991; 337:1235-43. Google Scholar3. Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, et al. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke. 1994; 25:2220-6. Google Scholar4. Interferon β-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The INFB Multiple Sclerosis Study Group. Neurology. 1993; 43:655-61. Google Scholar5. Paty DW, Li DK. Interferon β-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Neurology. 1993; 43:662-7. Google Scholar6. Ekbom KA. Restless legs syndrome. Neurology. 1960; 10:868-73. Google Scholar Author, Article, and Disclosure InformationAffiliations: From Brigham and Women's Hospital, Boston, Massachusetts.Corresponding Author: Martin A. Samuels, MD, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115.Current Author Addresses: Dr. Samuels: Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByBicyclic 6-6 Systems with One Bridgehead (Ring Junction) Nitrogen Atom: One Extra Heteroatom 1:0 1 October 1996Volume 125, Issue 7Page: 570-576KeywordsCarotid arteriesComputed axial tomographyDrug therapyDrugsEpileptic seizuresMagnetic resonance imagingNeuroimagingNeurologyStenosisStroke Issue Published: 1 October 1996 CopyrightCopyright © 1996 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...